Skip to content
Screener

McKesson MCK Prescription Technology Solutions — Exit and other-related costs

Other segment segments

Medical-Surgical Solutions
$9M-25.0%
North American Pharmaceutical
$1M

Similar metrics at other companies

Tyson Foods logo
TSNCorporate and Other — Business Exit Costs
$1.5M
Altria Group logo
MOSmokeable Products — Exit costs
$2M+100%
Timken logo
TKREngineered Bearings — Exit costs
-$100K
Timken logo
TKRIndustrial Motion — Exit costs
$200K0.0%
American Eagle Outfitters logo
AEOCorporate And Stores — Business Exit Costs1
$3.45M
Clarus Corporation logo
CLAROutdoor — Business Exit Costs1
$320K+967%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:BusinessExitCosts1.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)Three Months Ended June 30, 2026 / North American Pharmaceutical (1)Three Months Ended June 30, 2026 / Prescription Technology Solutions (1)Three Months Ended June 30, 2026 / Medical-Surgical Solutions (1)Three Months Ended June 30, 2026 / Corporate (1)Total
Severance and employee-related costs, net$11$14$7$32
Exit and other-related costs (2)11093757
Asset impairments and accelerated depreciation140647
Total$2$61$23$50$136

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's prescription technology solutions — exit and other-related costs?
McKesson (MCK) reported prescription technology solutions — exit and other-related costs of $10M in Q2 2026.
What is the long-term trend for McKesson's prescription technology solutions — exit and other-related costs?
Over 3 years (2022 to 2025), McKesson's prescription technology solutions — exit and other-related costs has grown at a -9.1% compound annual growth rate (CAGR), from $4M to $3M.
What does prescription technology solutions — exit and other-related costs mean?
Captures expenses associated with exiting specific business activities, facilities, or product lines within the Prescription Technology Solutions segment. These costs typically include lease terminations, contract cancellations, and other non-recurring expenses related to business unit consolidation.

Ask your AI about McKesson's prescription technology solutions — exit and other-related costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude